Kamada Ltd.
Kamada Ltd., a biopharmaceutical company traded on the Tel Aviv Stock Exchange, develops, produces and markets a line of specialty, life-saving therapeutics using a proprietary, sophisticated chromatographic purification technology. Kamada’s flagship intravenous AAT drug has been FDA approved for the treatment of Alpha-1 Antitrypsin Deficiency and is being marketed in the US under a strategic agreement with Baxter.
Kamada’s deep and diversified product pipeline also includes an inhaled version of AAT, currently in phase 3 clinical trials for the treatment of Alpha-1 Antitrypsin Deficiency, and intravenous AAT for treatment of Diabetes Type-1, currently in phase 1-2 trials.
Elbit Vision Systems Ltd.
Elbit Vision Systems Ltd. (EVS), an Israeli company traded in the US, is a global leader in the field of Automatic Optical Inspection, implemented in the production and quality control of fabrics and web.
EVS’ innovative systems improve product quality and increase production efficiency in hundreds of installations worldwide. Its products are used in a wide range of applications in the manufacturing of textiles for the automotive industry, technical fabrics, apparel, non-woven materials,
composite materials, coated fabrics, plastic films and more. EVS maintains its headquarters and manufacturing in Israel and offers global sales and support coverage.